Definitive Healthcare (DH) Stock Forecast, Price & News

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Definitive Healthcare in the last twelve months. There are currently 4 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" DH shares.
View DH analyst ratings or view top-rated stocks.

8 equities research analysts have issued 1-year target prices for Definitive Healthcare's stock. Their DH share price forecasts range from $10.00 to $15.50. On average, they expect the company's share price to reach $12.69 in the next year. This suggests a possible upside of 60.8% from the stock's current price.
View analysts price targets for DH or view top-rated stocks among Wall Street analysts.

Definitive Healthcare's stock was trading at $10.99 at the start of the year. Since then, DH stock has decreased by 28.2% and is now trading at $7.89.
View the best growth stocks for 2023 here.

Definitive Healthcare saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 7,990,000 shares, an increase of 24.8% from the August 31st total of 6,400,000 shares. Based on an average daily volume of 556,900 shares, the days-to-cover ratio is presently 14.3 days. Currently, 20.0% of the company's shares are sold short.
View Definitive Healthcare's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 2nd 2023.
View our DH earnings forecast.

Definitive Healthcare Corp. (NASDAQ:DH) released its earnings results on Monday, August, 14th. The company reported $0.08 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.05 by $0.03. The firm had revenue of $60.96 million for the quarter, compared to analyst estimates of $61 million. Definitive Healthcare had a negative net margin of 5.31% and a positive trailing twelve-month return on equity of 0.29%. The firm's revenue was up 11.7% on a year-over-year basis. During the same period last year, the business earned ($0.01) earnings per share.

ETFs with the largest weight of Definitive Healthcare (NASDAQ:DH) stock in their portfolio include Alger Weatherbie Enduring Growth ETF (AWEG), Fidelity Digital Health ETF (FDHT) and Global X Telemedicine & Digital Health ETF (EDOC).First Trust Nasdaq Lux Digital Health Solutions ETF (EKG).

Definitive Healthcare updated its third quarter 2023 earnings guidance on Monday, August, 14th. The company provided earnings per share guidance of $0.05-$0.07 for the period, compared to the consensus EPS estimate of $0.05. The company issued revenue guidance of $63.00 million-$64.50 million, compared to the consensus revenue estimate of $64.24 million.

(DH) raised $350 million in an initial public offering on Wednesday, September 15th 2021. The company issued 15,555,555 shares at a price of $21.00-$24.00 per share.

Definitive Healthcare trades on the NASDAQ under the ticker symbol "DH."

Definitive Healthcare's stock is owned by many different retail and institutional investors. Top institutional investors include Conestoga Capital Advisors LLC (4.94%), JPMorgan Chase & Co. (4.62%), Brown Advisory Inc. (3.58%), BlackRock Inc. (3.38%), Riverbridge Partners LLC (2.63%) and Clearbridge Investments LLC (2.06%). Insiders that own company stock include David Randall Winn, Jeffrey Charles Haywood, Richard Douglas Booth and Sea Vii Management, Llc.
View institutional ownership trends.

Shares of DH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of DH stock can currently be purchased for approximately $7.89.

Definitive Healthcare (NASDAQ:DH) has a market capitalization of $893.94 million and generates $222.65 million in revenue each year. The company earns $-7,220,000.00 in net income (profit) each year or ($0.15) on an earnings per share basis.

The company employs 946 workers across the globe.

Definitive Healthcare's mailing address is 550 COCHITUATE ROAD, FRAMINGHAM MA, 01701. The official website for the company is www.definitivehc.com. The company can be reached via phone at 508-720-4224 or via email at ir@definitivehc.com.